Mesothelin Vaccination for the Prevention of Ovarian CancerPOP: 09/15/2014-09/14/2016Preclinical Efficacy and Intermediate Endpoint BiomarkersHHSN261201200014I
$642,541N01FY2014CANIH
Sri International, Menlo Park CA
Investigators
Abstract
This project will assess the potential cancer chemopreventive vaccine using mouse models.
View original record on NIH RePORTER →